probably 96-97. Each cultivar has different optimal growing...

probably 96-97.
Each cultivar has different optimal growing requirements, e.g. nutrient uptake, lighting regimes, propagation techniques, etc. Time is needed to work this out. Cann has not done this. They have one method for all strains. Moreover, they have not determined their hero line. Collaborations with Southern Cross and La Trobe Univeristy brings in some research elements, but as yet there is no mechanism to implement any findings to production. As I said, the focus is on the business, not the product. You can put just about any cannabis material through an extractor to generate CBD oil, but cannabis users/patients often want quality. With so many products on the market, Cann needs to set itself apart and that is going to be hard using their current methods. Its also naive to think they can get away with subpar weed. Again, not saying they wont be profitable. Just something for investors to keep in mind.